PRA Health Sciences (PRAH) Tops Q3 EPS by 7c; Lifts FY15 EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500, Nasdaq set for higher open as investors weigh weaker oil, PPI data
- Oil falls on weaker demand outlook and higher US stocks
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Birkenstock surges on revenue beat, higher full-year outlook
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Avondale Partners Downgrades PRA Health Sciences (PRAH) to Underperform
November 4, 2015 7:59 AM ESTAvondale Partners downgraded PRA Health Sciences (NASDAQ: PRAH) from Market Perform to Underperform with a price target of $31.50.
For an analyst ratings summary and ratings history on PRA Health Sciences click here. For more ratings news on PRA Health Sciences click here.
Shares of PRA Health Sciences closed at $41.31 yesterday.
... More